FILE - In this Tuesday, Dec. 6, 2011, file photo, an Occupy Wall Street activist places tape on a boarded up house during a tour of foreclosed homes in the East New York neighborhood of the Brooklyn borough of New York. Goldman Sachs and Morgan Stanley announced Jan. 16, 2013, they will pay a combined $557 million to settle federal complaints that they wrongfully foreclosed on homeowners who should have been allowed to stay in their homes. (AP Photo/Mary Altaffer, File)
Mylan names 2 to board, including co. president
Published: 04:32:54 PM, Mon 11 February 2013 UTC
PITTSBURGH (AP) — Mylan Inc. said Monday that it has added two new members to its board of directors, expanding it to 13 members.
The pharmaceutical company's board appointed Melina Higgins, a former partner at Goldman, Sachs & Co., and Rajiv Malik, Mylan's president, to the board.
Higgins joined Goldman Sachs in 1989 and retired in 2010 after serving as a partner and in various leadership roles.
Malik has held important leadership positions at Mylan since January 2007, when the company acquired a controlling stake in Matrix Laboratories Ltd., now Mylan Laboratories Ltd. Malik was the CEO of the active pharmaceutical ingredients supplier.
Mylan Executive Chairman Robert J. Coury said the appointments deliver on the company's objective of strengthening Mylan at all levels.
Mylan markets the EpiPen, an epinephrine auto-injector for treating severe allergic reactions. Pfizer Inc. makes EpiPen, and Mylan markets it in the U.S. Mylan also makes generic and specialty prescription drugs.
Shares of the Pittsburgh company fell 5 cents to $28.81 in midmorning trading, in line with broader market trends.
Tags:
ap, pfizer inc., goldman sachs, lloyd blankfein, mylan, henry paulson, mylan inc., rajiv malik, melina higgins, robert j. coury, matrix laboratories ltd., cents, monday, appointments, new members, chairman, stake, ceo, board, co., directors, partner, business, company, president, board of directors, pharmacology, marcus goldman, objective, pharmaceutical company, broader market trends, mylan markets, malik, mylan executive chairman, various leadership roles, severe allergic reactions, important leadership positions, active pharmaceutical ingredients, specialty prescription drugs, mylan names, epipen, mylan laboratories, epinephrine auto-injector, u.s. mylan, pittsburgh company, midmorning trading
